Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Saxagliptin Hydrochloride

    Client Email Product

    Saxagliptin Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    17
    US DMFs Filed

    US DMFs Filed

    12
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    8
    Other Suppliers

    Other Suppliers

    7
    API REF. PRICE (USD / KG)
    18,227

    API Market Place

    1
    INTERMEDIATES
    2
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    30
    Europe

    Europe

    2
    Canada

    Canada

    9
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,716.00

    Annual Reports

    820.00

    FDF Market Place

    0

    EXCIPIENTS
    116
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    50

    USFDA Exclusivities

    4
    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    12
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE
    • TABLET;ORAL - EQ 2.5MG BASE
    • TABLET;ORAL - EQ 5MG BASE
    Full View ScreenFull Screen View
    Dr. Reddy's Generic Metformin & Saxagliptin Hydrochloride Receives Approval in the U.S.
    Dr. Reddy's Generic Metformin & Saxagliptin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207678

    FDA
    09 Aug 2023
    Share Share
    Sun Pharm`s Generic Saxagliptin HCL Receives Tentative Approval In Us
    Sun Pharm`s Generic Saxagliptin HCL Receives Tentative Approval In Us

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206078

    FDA
    05 Mar 2020
    Share Share
    Merck's DPP-4 newcomer Marizev trails Januvia in safety: Report
    Merck's DPP-4 newcomer Marizev trails Januvia in safety: Report

    http://www.fiercepharma.com/pharma/merck-s-dpp-4-newcomer-marizev-trails-januvia-safety-report

    Emily Wasserman FIERCE PHARMA
    15 Apr 2016
    Share Share
    Colombian government recommendation puts Novartis cancer drug patent at jeopardy
    Colombian government recommendation puts Novartis cancer drug patent at jeopardy

    http://www.statnews.com/pharmalot/2016/03/07/novartis-gleevec-cancer/

    Ed Silverman STAT
    08 Mar 2016
    Share Share
    FDA warning on J&J's Invokana adds more complexities to diabetes drug battles
    FDA warning on J&J's Invokana adds more complexities to diabetes drug battles

    http://www.fiercepharma.com/story/fda-warning-jjs-invokana-adds-more-complexities-diabetes-drug-battles/2015-09-11?utm_medium=rss&utm_source=rss&utm_campaign=rss

    Eric Palmer FIERCE PHARMA
    12 Sep 2015
    Share Share
    FDA warns of severe joint pain risk with DPP-4 diabetes drugs
    FDA warns of severe joint pain risk with DPP-4 diabetes drugs

    http://in.reuters.com/article/2015/08/28/us-diabetes-drugs-warning-idINKCN0QX25E20150828

    Toni Clarke REUTERS
    29 Aug 2015
    Share Share
    India rejects Lee Pharma’s compulsory licence plea
    India rejects Lee Pharma’s compulsory licence plea

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-rejects-lee-pharmas-compulsory-licence-plea/articleshow/48521191.cms

    Ruchika Chitravanshi THE ECONOMIC TIMES
    18 Aug 2015
    Share Share
    High Court rejects AstraZeneca’s diabetes drug plea
    High Court rejects AstraZeneca’s diabetes drug plea

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/high-court-rejects-astrazenecas-diabetes-drug-plea/articleshow/48274835.cms

    ET Bureau THE ECONOMIC TIMES
    29 Jul 2015
    Share Share
    AstraZeneca, Dr Reddy's ink diabetes drug distribution pact
    AstraZeneca, Dr Reddy's ink diabetes drug distribution pact

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-dr-reddys-ink-diabetes-drug-distribution-pact/articleshow/47472977.cms

    Press Trust Of India THE ECONOMIC TIMES
    30 May 2015
    Share Share
    AstraZeneca's Onglyza 'Mortality' Risks Noted By FDA Reviewers
    AstraZeneca's Onglyza 'Mortality' Risks Noted By FDA Reviewers

    http://www.fiercepharma.com/story/astrazenecas-onglyza-mortality-risks-noted-fda-reviewers/2015-04-10

    Eric Palmer FIERCE PHARMA
    13 Apr 2015
    Share Share
    AZ's Onglyza Has Most to Lose at FDA Safety Confab, Analysts Say
    AZ's Onglyza Has Most to Lose at FDA Safety Confab, Analysts Say

    http://www.fiercepharma.com/story/azs-onglyza-has-most-lose-fda-safety-confab-analysts-say/2015-04-09

    Tracy Staton FIERCE PHARMA
    10 Apr 2015
    Share Share
    Astrazeneca Bullish on Diabetes Franchise Fortunes
    Astrazeneca Bullish on Diabetes Franchise Fortunes

    http://www.pmlive.com/pharma_news/astrazeneca_bullish_on_diabetes_franchise_fortunes_676415

    Ben Adams PMLIVE
    13 Mar 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search